pharmaphorum April 26, 2024
Nicole Raleigh

Chemists at ETH Zurich have developed a new computer process that enables the generation of active pharmaceutical ingredients at speed, based on a protein’s three-dimensional surface.

The new generative AI (GenAI) develops molecules from scratch in a way that precisely matches the protein they are intended to interact with. Thought to offer a potential to “revolutionise drug research”, the new computer process ensures that the molecules can also be chemically synthesised.

“It’s a real breakthrough for drug discovery,” said Professor Gisbert Schneider, of ETH Zurich’s Department of Chemistry and Applied Biosciences.

Together with his former doctoral student Kenneth Atz, Prof Schneider developed an algorithm that uses AI to design new active pharmaceutical ingredients. For any protein with a known three-​dimensional...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Technology
Related Articles:
OpenAI partners with Stack Overflow to make models better at coding
How can AI companies navigate a complex regulatory framework? — Compliance Labels
If AI Harms A Patient, Who Gets Sued?
Nvidia's DrEureka outperforms humans in training robotics systems
4 ways GenAI in healthcare improves patient experiences

Share This Article